50 Years of progress in the systemic therapy of non-small cell lung cancer. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting Wakelee, H., Kelly, K., Edelman, M. J. 2014: 177–89


Non-small cell lung cancer constitutes 85% to 90% of lung cancer and is the most common cause of cancer death. Over the past 50 years, substantial progress has been made in all aspects of lung cancer including screening, diagnostic evaluation, surgery, radiation therapy, and chemotherapy. This review focuses on the advances in systemic therapy during this half century.

View details for PubMedID 24857075